Psoriasis and ischemic heart disease: A case-control study

Giornale Italiano di Dermatologia e Venereologia

Volumn 142, Issue 4, 2007, Pages 299-302

  Cohen, A D ^a,b,g   Shapiro, Y ^c   Davidovici, B ^d   Meyerovitch, J ^a,e,f   Vidavsky, L ^a   Vardy, D A ^a,b   Shalev, R ^a,b   Sikurel, A ^a,b   Dreiher, J ^a,b  

^a CLALIT HEALTH SERVICES   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

^g Institute for Endocrinology and Diabetes National Center for Childhood Sackler School of Medicine Tel Aviv University ^*  (Israel)

Author keywords

Coronary artery disease; Psoriasis, diagnosis; Risk factors

Indexed keywords

ETRETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INFANT; ISCHEMIC HEART DISEASE; ISRAEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHOTOTHERAPY; PSORIASIS; PUVA; RISK ASSESSMENT; SEX DIFFERENCE; ULTRAVIOLET B RADIATION;

EID: 36048951133     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res 2005;32:45-56.
2. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003; 49(2 Suppl):S44-S50.
3. Alberti KG, Zimmet P. The metabolic syndrome: time to reflect. Curr Diab Rep 2006;6:259-61.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
5. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62.
6. Zambon A, Pauletto P, Crepaldi G. Review article: the metabolic syndrome - a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 2005;22 Suppl 2:20-3.
7. Timar O, Sestier F, Levy E. Metabolic syndrome X: a review. Can J Cardiol 2000;16:779-89.
8. Lopez-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med 2001;32:283-300.
9. Christophers E. Comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2006;20 Suppl 2:52-5.
10. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41.
11. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-6.
12. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986;172:298-304.
13. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30.
14. Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-63.
15. Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:614-21.
16. McDonald CJ, Calabresi P. Complication of psoriasis. JAMA 1973;224:629.
17. McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch Dermatol 1973;107:918.
18. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med 1973;288:912.
19. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978;99:469-75.
20. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007;56:629-34.
21. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298:321-8.
22. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1-9.
23. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007;66:208-14.
24. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2007 Jan 29; [Epub ahead of print]
25. Naldi L, Chatenoud L, Linder D, Belloni FA, Peserico A, Virgili AR et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005;125:61-7.